We are live on ! Find out more
QTTB icon

Q32 Bio

119 hedge funds and large institutions have $252M invested in Q32 Bio in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $1.42M | Put options by funds: $866K

24% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 29

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

5% more capital invested

Capital invested by funds: $240M → $252M (+$12.4M)

1% more funds holding

Funds holding: 118119 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.09% less ownership

Funds ownership: 3.21%3.12% (-0.09%)

Holders
119
Holders Change
+1
Holders Change %
+0.85%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
16
Increased
36
Reduced
29
Closed
14
Calls
$1.42M
Puts
$866K
Net Calls
+$554K
Net Calls Change
+$1.27M

QTTB Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2021, worth a combined $252M — up 5.2% from $240M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new QTTB positions and 14 closed out — a net gain of 2 holders — while 36 added to existing stakes and 29 trimmed.

The largest buyer was Temasek Holdings, adding an estimated $16.8M. The largest seller was Wellington Management Group, cutting an estimated $11.4M.

  • 119 institutional investors held Q32 Bio (QTTB) as of Q3 2021, up from 118 in Q2 2021.
  • Funds reported $252M of Q32 Bio stock for Q3 2021, up 5.2% quarter-over-quarter.
  • 16 funds opened new Q32 Bio positions in Q3 2021 and 14 closed out, a net change of +2 holders.
  • The largest Q32 Bio buyer in Q3 2021 was Temasek Holdings, an estimated $16.8M added.
  • The largest Q32 Bio seller in Q3 2021 was Wellington Management Group, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2021.